The UK’s Prescription Medicines Code of Practice Authority (PMCPA) issued the final resolution in its case pertaining to the nature of Gossamer Bio’s presence at a meeting for healthcare professionals.
The PMCPA case summary relates to multiple complaints allegedly in violation of the Association of the British Pharmaceutical